Crónica de una muerte anunciada? The ECJ judgment Lactalis and what’s left of the «made in» question in the European Union
DOI:
https://doi.org/10.18042/cepc/rdce.68.10Abstract
The EU Regulation 1169/2011 on food information to consumers provided many exceptions to the rule which states the general irrelevance of origin in food labelling and stated that Member States have the possibility to impose further mandatory information about origin/place of provenance for some categories of quality products.
On this ground, many Member States introduced in recent years national rules about origin, feeding the so-called “battle on transparency and made-in declarations”.
The European Court of Justice in the judgment in comment stated that:
– The general rule contained in Art. 26.2 of the Regulation, although laconic, is an absolute pre-emption of the matter.
– Art. 39, which allows Member States to add some further mandatory particulars to the list of the Regulation, is limited to products whose qualities depend on the geographical origin and only at the condition that consumers consider this information essential;
– The risk of deterioration of milk, due to the long-distance transport is not covered by Art. 39.
In this way, a window of opportunity seems definitely closed for those who support the “made-in battle”, considering that the ECJ has adopted an orthodox approach, coherent with the rules of free circulation of goods in the internal market.
This comment, starting from this point, highlights the consequences in the short term of this judgment, and envisages how in the future this fight could carry on.
Published
Issue
Section
License
Copyright
Submission of a manuscript to the RDCE implies having read and accepted the journal's editorial guidelines and instructions for authors. When a work is accepted for publication, it is understood that the author grants the RDCE exclusive rights of reproduction, distribution and, where appropriate, sale of his manuscript for exploitation in all countries of the world in printed version, as well as any other magnetic, optical and digital media.
Authors shall transfer the publishing rights of their manuscript to RDCE so that it may be disseminated and capitalised on Intranets, the Internet and any web portals and wireless devices that the publisher may decide, by placing it at the disposal of users so that the latter may consult it online and extract content from it, print it and/or download and save it. These activities must comply with the terms and conditions outlined on the website hosting the work. However, the RDCE authorises authors of papers published in the journal to include a copy of these papers, once published, on their personal websites and/or other open access digital repositories. Copies must include a specific mention of RDCE, citing the year and issue of the journal in which the article was published, and adding a link to the RDCE website(s).
A year after its publication, the works of the RDCE will be under the Creative Commons Attribution-Noncommercial-NoDerivative 4.0 International license (CC BY-NC-ND 4.0), which allows third parties to share the work as long as its author and its first publication is indicated, without the right to commercial exploitation and the elaboration of derivative works.
Plagiarism and scientific fraud
The publication of work that infringes on intellectual property rights is the sole responsibility of the authors, including any conflicts that may occur regarding infringement of copyright. This includes, most importantly, conflicts related to the commission of plagiarism and/or scientific fraud.
Practices constituting scientific plagiarism are as follows:
1. Presenting the work of others as your own.
2. Adopting words or ideas from other authors without due recognition.
3. Not using quotation marks or another distinctive format to distinguish literal quotations.
4. Giving incorrect information about the true source of a citation.
5. The paraphrasing of a source without mentioning the source.
6. Excessive paraphrasing, even if the source is mentioned.
Practices constituting scientific fraud are as follows:
1. Fabrication, falsification or omission of data and plagiarism.
2. Duplicate publication.
3. Conflicts of authorship.
Warning
Any breach of these Rules shall constitute a ground for rejection of the manuscript submitted.
